Vemurafenib for BRAFV600E-positive Metastatic Papillary Thyroid Cancer – Authors' Response

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(16)30520-4
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Elsevier BV